![](/-/media/project/common/viatriscomau/images/news_in_australia/aus_news_module2_nr_1038x1058_au.jpg?h=1058&iar=0&w=1038&hash=3D9FD84B414361D67928F6F7660B43D6)
2023
- Viatris Australia reaches new milestone with the addition of Aussie Made Logo on medicines
- It ain’t easy being sneezy: 1 in 5 Australians relieved with new hay fever therapy access
- Viatris Australia Launches New Campaign Highlighting Visionary Voices in Healthcare
- Viatris Australia renews strategic relationship with National Pharmacies and supports recycling of pharmaceutical waste to safeguard the environment
- Viatris Australia welcomes improved access to migraine treatment with Relpax® Migraine (eletriptan) since the down-scheduling of triptans
- Viatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine
2022
- Through collaboration Viatris Australia takes the ‘I’ out of iron deficiency
- Viatris Australia named one of the best workplaces to give back
- New state-of-the art addition expands one of Australia's medicine facilities
- Viatris partners with Terry White Chemmart, Pharmacy Choice and healthSAVE to provide access to high quality and affordable medicines.